FY2024 Earnings Forecast for ACHC Issued By KeyCorp

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Analysts at KeyCorp issued their FY2024 earnings per share (EPS) estimates for Acadia Healthcare in a research note issued to investors on Monday, January 6th. KeyCorp analyst M. Gillmor expects that the company will earn $3.39 per share for the year. KeyCorp has a “Overweight” rating and a $70.00 price objective on the stock. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. KeyCorp also issued estimates for Acadia Healthcare’s Q4 2024 earnings at $0.73 EPS, Q1 2025 earnings at $0.66 EPS, Q4 2025 earnings at $0.77 EPS, FY2025 earnings at $3.20 EPS and FY2026 earnings at $3.98 EPS.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm had revenue of $815.60 million during the quarter, compared to analysts’ expectations of $819.42 million. During the same period in the prior year, the company posted $0.91 earnings per share. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year.

A number of other equities research analysts have also issued reports on ACHC. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and increased their price objective for the company from $45.00 to $75.00 in a report on Thursday, December 12th. Royal Bank of Canada reduced their price target on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a report on Monday, November 18th. TD Cowen dropped their price objective on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a report on Tuesday. Cantor Fitzgerald restated a “neutral” rating and set a $52.00 price objective on shares of Acadia Healthcare in a research report on Tuesday, December 10th. Finally, Barclays decreased their target price on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a research report on Friday, November 22nd. One analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $70.22.

Acadia Healthcare Stock Performance

NASDAQ ACHC opened at $45.12 on Thursday. The business has a 50-day moving average price of $40.43 and a 200-day moving average price of $58.28. The firm has a market cap of $4.19 billion, a price-to-earnings ratio of 14.79, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29. Acadia Healthcare has a twelve month low of $36.50 and a twelve month high of $87.77. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Point72 Asset Management L.P. boosted its holdings in Acadia Healthcare by 266.0% during the 2nd quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company’s stock valued at $153,339,000 after acquiring an additional 1,650,040 shares during the period. Wellington Management Group LLP boosted its stake in shares of Acadia Healthcare by 12.2% during the third quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock valued at $739,250,000 after purchasing an additional 1,266,384 shares during the period. Millennium Management LLC grew its holdings in shares of Acadia Healthcare by 3,067.8% in the second quarter. Millennium Management LLC now owns 1,090,313 shares of the company’s stock worth $73,640,000 after purchasing an additional 1,055,894 shares during the last quarter. Holocene Advisors LP increased its stake in Acadia Healthcare by 201.5% in the 3rd quarter. Holocene Advisors LP now owns 972,513 shares of the company’s stock worth $61,667,000 after buying an additional 649,997 shares during the period. Finally, William Blair Investment Management LLC boosted its position in Acadia Healthcare by 20.7% in the 2nd quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock valued at $237,434,000 after buying an additional 604,070 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.